NDC 72934-4025

BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7%

Betamethasone Diproprionate 0.05% / Minoxidil 7%

BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7% is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Betamethasone Dipropionate; Minoxidil.

Product ID72934-4025_8875a838-5a95-3407-e053-2a95a90ae3eb
NDC72934-4025
Product TypeHuman Prescription Drug
Proprietary NameBETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7%
Generic NameBetamethasone Diproprionate 0.05% / Minoxidil 7%
Dosage FormSolution
Route of AdministrationTOPICAL
Marketing Start Date2019-05-10
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameBETAMETHASONE DIPROPIONATE; MINOXIDIL
Active Ingredient Strength0 g/100g; g/100g
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-4025-8

60 g in 1 BOTTLE, GLASS (72934-4025-8)
Marketing Start Date2019-05-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-4025-8 [72934402508]

BETAMETHASONE DIPROPRIONATE 0.05% / MINOXIDIL 7% SOLUTION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-10

Drug Details

Active Ingredients

IngredientStrength
BETAMETHASONE DIPROPIONATE.05 g/100g

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Arteriolar Vasodilation [PE]
  • Arteriolar Vasodilator [EPC]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Arteriolar Vasodilation [PE]
  • Arteriolar Vasodilator [EPC]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.